Protecting the antibodies

Mewburn Ellis’ Rebecca Tollervey examines what do the new European Patent Office guidelines mean for the patenting of highly engineered antibodies?

Rebecca Tollervey, Mewburn Ellis

The introduction of a section into the European Patent Office (EPO) Guidelines for Examination specifically concerning the patentability requirements of antibodies is a welcome development. ¹